@article{c169aed122ad4ee7939195b7f97276c5,
title = "Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings",
abstract = "To compare the structural outcome at 9 months of eyes treated with intravitreal injection of bevacizumab with fellow eyes treated with conventional laser photoablation in zone I type 1 retinopathy of prematurity (ROP).",
keywords = "INTRAVITREAL, ROP, INTRAVITREAL, ROP",
author = "Domenico Lepore and Quinn, {Graham E.} and Fernando Molle and Antonio Baldascino and Lorenzo Orazi and {Sammartino Sinicalco}, Maria and Velia Purcaro and Carmen Giannantonio and Patrizia Papacci and Costantino Romagnoli",
year = "2014",
doi = "10.1016/j.ophtha.2014.05.015",
language = "English",
volume = "121",
pages = "2212--2219",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "-ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 -Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL:
[email protected], INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320",
}